AbCellera Biologics Inc. ABCL Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization?
- AbCellera Biologics Inc. (ABCL) reported finite-lived intangible assets, accumulated amortization of $31.86M in Q1 2026.
- How has AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization decreased by 36.2% year-over-year, from $49.94M to $31.86M.
- What is the long-term trend for AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization has grown at a -5.6% compound annual growth rate (CAGR), from $34.72M to $30.94M.